E2F-1:DP-1 induces p53 and overrides survival factors to trigger apoptosis
- PMID: 8524253
- PMCID: PMC230941
- DOI: 10.1128/MCB.15.12.6864
E2F-1:DP-1 induces p53 and overrides survival factors to trigger apoptosis
Abstract
The E2F DNA binding activity consists of a heterodimer between E2F and DP family proteins, and these interactions are required for association of E2F proteins with pRb and the pRb-related proteins p107 and p130, which modulate E2F transcriptional activities. E2F-1 expression is sufficient to release fibroblasts from G0 and induce entry into S phase, yet it also initiates apoptosis. To investigate the mechanisms of E2F-induced apoptosis, we utilized interleukin-3 (IL-3)-dependent 32D.3 myeloid cells, a model of hematopoietic progenitor programmed cell death. In the absence of IL-3, E2F-1 alone was sufficient to induce apoptosis, and p53 levels were diminished. DP-1 alone was not sufficient to induce cell cycle progression or alter rates of death following IL-3 withdrawal. However, overexpression of both E2F-1 and DP-1 led to the rapid death of cells even in the presence of survival factors. In the presence of IL-3, levels of endogenous wild-type p53 increased in response to E2F-1, and coexpression of DP-1 further augmented p53 levels. These results provide evidence that E2F is a functional link between the tumor suppressors p53 and pRb. However, induction of p53 alone was not sufficient to trigger apoptosis, suggesting that the ability of E2F to override survival factors involves additional effectors.
Similar articles
-
Functional interaction between DP-1 and p53.Mol Cell Biol. 1996 Oct;16(10):5888-95. doi: 10.1128/MCB.16.10.5888. Mol Cell Biol. 1996. PMID: 8816502 Free PMC article.
-
E2F-1 cooperates with topoisomerase II inhibition and DNA damage to selectively augment p53-independent apoptosis.Mol Cell Biol. 1997 Mar;17(3):1049-56. doi: 10.1128/MCB.17.3.1049. Mol Cell Biol. 1997. PMID: 9032231 Free PMC article.
-
Deregulated expression of E2F family members induces S-phase entry and overcomes p16INK4A-mediated growth suppression.Mol Cell Biol. 1996 Mar;16(3):1047-57. doi: 10.1128/MCB.16.3.1047. Mol Cell Biol. 1996. PMID: 8622649 Free PMC article.
-
The cellular effects of E2F overexpression.Curr Top Microbiol Immunol. 1996;208:79-93. doi: 10.1007/978-3-642-79910-5_4. Curr Top Microbiol Immunol. 1996. PMID: 8575214 Review.
-
The role of the transcription factor DP in apoptosis.Apoptosis. 2003 Oct;8(5):461-8. doi: 10.1023/a:1025586207239. Apoptosis. 2003. PMID: 12975577 Review.
Cited by
-
Activation of cell cycle arrest and apoptosis by the proto-oncogene Pim-2.PLoS One. 2012;7(4):e34736. doi: 10.1371/journal.pone.0034736. Epub 2012 Apr 10. PLoS One. 2012. PMID: 22506047 Free PMC article.
-
Cyclin-dependent kinases and P53 pathways are activated independently and mediate Bax activation in neurons after DNA damage.J Neurosci. 2001 Jul 15;21(14):5017-26. doi: 10.1523/JNEUROSCI.21-14-05017.2001. J Neurosci. 2001. PMID: 11438577 Free PMC article.
-
Induction of the cellular E2F-1 promoter by the adenovirus E4-6/7 protein.J Virol. 2000 Mar;74(5):2084-93. doi: 10.1128/jvi.74.5.2084-2093.2000. J Virol. 2000. PMID: 10666238 Free PMC article.
-
TFDP3 as E2F Unique Partner, Has Crucial Roles in Cancer Cells and Testis.Front Oncol. 2021 Oct 20;11:742462. doi: 10.3389/fonc.2021.742462. eCollection 2021. Front Oncol. 2021. PMID: 34745961 Free PMC article. Review.
-
Modulation of the E2F1-driven cancer cell fate by the DNA damage response machinery and potential novel E2F1 targets in osteosarcomas.Am J Pathol. 2009 Jul;175(1):376-91. doi: 10.2353/ajpath.2009.081160. Epub 2009 Jun 18. Am J Pathol. 2009. PMID: 19541929 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous